Our study not only includes these indices but also incorporates a range of lung cancer-related tumour markers, such as CEA, NSE, CYFRA21, and SCCA, which have a potential impact on the prognosis of NSCLC patients with BM. This evidence concerns the gene ENO2 and neoplasm.